Scandinavian ChemoTech AB Series B Financial Flexibility Index
Scandinavian ChemoTech AB Series B financial flexibility index. Scandinavian ChemoTech AB Series B (CMOTEC-B) has a Financial Flexibility Index of -0.19x as of June 2026. Free cash flow of Skr-1.78 Million (operating CF Skr-1.78 Million minus capex Skr0.00) represents 0% of total liabilities (Skr9.49 Million). See free cash flow generation of Scandinavian ChemoTech AB Series B to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Scandinavian ChemoTech AB Series B (2014–2025)
Financial flexibility index of Scandinavian ChemoTech AB Series B from 2014 to 2025. Historical Financial Flexibility Index trend for Scandinavian ChemoTech AB Series B across 12 annual periods. Explore how well can Scandinavian ChemoTech AB Series B service its debt to assess how comfortably operating cash covers total debt obligations.
Scandinavian ChemoTech AB Series B Financial Flexibility Index by Year (2014–2025)
Scandinavian ChemoTech AB Series B financial flexibility index by year from 2014 to 2025. Year-by-year free cash flow to debt coverage for Scandinavian ChemoTech AB Series B. For the full cash flow conversion analysis, see cash efficiency ratio of Scandinavian ChemoTech AB Series B.
| Year | Flexibility Index | Free Cash Flow (SEK) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.33x | Skr-3.31 Million | Skr-3.75 Million | Skr10.01 Million | ▲ +81.3% |
| 2024 | -1.77x | Skr-13.10 Million | Skr-13.14 Million | Skr7.40 Million | ▲ +61.3% |
| 2023 | -4.57x | Skr-17.55 Million | Skr-18.23 Million | Skr3.84 Million | ▼ -82.6% |
| 2022 | -2.50x | Skr-19.30 Million | Skr-19.63 Million | Skr7.71 Million | ▲ +70.4% |
| 2021 | -8.45x | Skr-16.00 Million | Skr-19.18 Million | Skr1.89 Million | ▼ -756.7% |
| 2020 | -0.99x | Skr-6.67 Million | Skr-8.49 Million | Skr6.75 Million | ▼ -10.8% |
| 2019 | -0.89x | Skr-6.91 Million | Skr-11.23 Million | Skr7.76 Million | ▼ -359.7% |
| 2018 | -0.19x | Skr-448.00K | Skr-4.58 Million | Skr2.31 Million | ▲ +95.4% |
| 2017 | -4.19x | Skr-10.70 Million | Skr-14.97 Million | Skr2.56 Million | ▼ -26.6% |
| 2016 | -3.31x | Skr-7.42 Million | Skr-7.52 Million | Skr2.24 Million | ▼ -853.9% |
| 2015 | 0.44x | Skr2.54 Million | Skr-474.99K | Skr5.78 Million | ▲ +143.9% |
| 2014 | -1.00x | Skr-19.61K | Skr-40.91K | Skr19.63K | — |